Current perspective on rituximab in rheumatic diseases
Tommaso Schioppo, Francesca Ingegnoli Department of Clinical Sciences and Community Health, Division of Rheumatology, ASST Pini, Università degli Studi di Milano, Milano, Italy Abstract: The steadily increasing knowledge regarding pathogenetic mechanisms in autoimmune rheumatic diseases has paved t...
Saved in:
Main Authors: | Schioppo T (Author), Ingegnoli F (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
On- and off-label use of rituximab in rheumatic diseases
by: Gilda Sandri, et al.
Published: (2021) -
Disease disclosure in the workplace in people living with rheumatic diseases: an exploratory study
by: S.M.T. Ostuzzi, et al.
Published: (2024) -
Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives
by: Moog P, et al.
Published: (2015) -
Rheumatic heart disease screening: Current concepts and challenges
by: Scott Dougherty, et al.
Published: (2017) -
Current Status and Future Challenges in the Treatment of Rheumatic Diseases
by: Enrique R. Soriano
Published: (2022)